Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2317 | Meditation and Anxiety Reduction Training Wiki | 1.00 |
| drug556 | Bimekizumab Wiki | 1.00 |
| drug328 | Anxiety Reduction Training Wiki | 1.00 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This randomized clinical on-line study examines whether whether a daily practice of meditation or Kundalini Yoga with anxiety reduction training leads to a greater reduction in anxiety than anxiety reduction training alone.
Description: Generalized Anxiety Disorder 7-item scale (range 0-21, higher is worse)
Measure: GAD-7 Time: Up to 32 weeksDescription: Health Anxiety 8-item scale (range 0-32, higher is worse)
Measure: Whiteley 8 Time: Up to 32 weeksDescription: Patient Health Questionnaire 8 - an 8 item measure of depression (range 0-24, higher is worse)
Measure: PHQ-8 Time: Up to 32 weeksDescription: Somatic Symptom Scale-8 an 8-item measure of symptom burden (range 0-32, higher is worse)
Measure: SS-8 Time: Up to 32 weeksDescription: An 8-item self-report measure of cognitive function (range 8-40, higher is worse)
Measure: Applied Cognition 1.0 Time: Up to 32 weeksDescription: A 4-item self-report assessment of sleep disturbance (range 4-20, higher is worse)
Measure: PROMIS-4 Sleep Disturbance Time: Up to 32 weeksDescription: Emotional Regulation Questionnaire - a 10-item measure of emotional regulation; the reappraisal subscale has a range: of 6-42, higher score is considered positive; while the suppression subscale has a range of 4-28, higher score considered negative. ..
Measure: ERQ Time: Up to 32 weeksDescription: A 10-item scale assessing the perception of events in one's life as stressful (0-40, higher represents higher perception of stress)
Measure: Perceived Stress Scale Time: Up to 32 weeksDescription: A 5-item scale assessing hypervigilance (0-20, higher represents greater hypervigilance)
Measure: Brief Hypervigilance Scale Time: Up to 32 weeksAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports